person_alumni

Dr. Zuzana Chyra, an accomplished researcher specializing in hematologic malignancies mainly in molecular and cell biology of multiple myeloma and AL amyloidosis. Currently, she is focused on investigating approaches to NK cell-based immunotherapy in her research pursuits. Dr. Chyra’s extensive experience includes position at renowned institution such as the Jerome Lipper Multiple Myeloma Center at

Dr. Matouš Hrdinka stands at the forefront of cancer biology and molecular immunology research, focusing on uncovering the intricate mechanisms of ubiquitin and kinase oncogenic signaling and advancing antibody and cell-based immunotherapies. With over a decade of experience in both academic and pharmaceutical sectors, Dr. Hrdinka has distinguished himself as an accomplished senior scientist and